Downregulation of miR-16 promotes growth and motility by targeting HDGF in non-small cell lung cancer cells

FEBS Letters

Volumn 587, Issue 18, 2013, Pages 3153-3157

  Ke, Yang ^a   Zhao, Weiyong ^b   Xiong, Jie ^a   Cao, Rubo ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b THE SECOND AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Growth; HDGF; Invasion; Migration; miR 16; Non small cell lung cancer

Indexed keywords

HEPATOMA DERIVED GROWTH FACTOR; MICRORNA 16;

ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CELL GROWTH; CELL MOTILITY; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; GENE FUNCTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LUNG NON SMALL CELL CANCER; MIGRATION INHIBITION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN RNA BINDING; PROTEIN TARGETING;

GROWTH; HDGF; INVASION; MIGRATION; MIR-16; NON-SMALL CELL LUNG CANCER;

BINDING SITES; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, REPORTER; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LUCIFERASES; LUNG NEOPLASMS; MICRORNAS; PRIMARY CELL CULTURE; PROTEIN BINDING; SIGNAL TRANSDUCTION;

EID: 84883490721     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1016/j.febslet.2013.08.010     Document Type: Article

References (21)

1. N. Zhang, X. Wei, and L. Xu MiR-150 promotes the proliferation of lung cancer cells by targeting P53 FEBS Lett. 587 2013 2346 2351
2. R. Siegel, E. Ward, O. Brawley, and A. Jemal Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths CA Cancer J. Clin. 61 2011 212 236
3. L. Boyero, A. Sanchez-Palencia, M.T. Miranda-Leon, F. Hernandez-Escobar, J.A. Gomez-Capilla, and M.E. Farez-Vidal Survival, classifications, and desmosomal plaque genes in non-small cell lung cancer Int. J. Med. Sci. 10 2013 1166 1173
4. X. Shaoyan, Y. Juanjuan, T. Yalan, H. Ping, L. Jianzhong, and W. Qinian Downregulation of EIF4A2 in non-small-cell lung cancer associates with poor prognosis 2013 Clin. Lung Cancer 10.1016/j.cllc.2013.04.011
5. F.P. Vendetti, and C.M. Rudin Epigenetic therapy in non-small-cell lung cancer: targeting DNA methyltransferases and histone deacetylases Expert. Opin. Biol. Ther. 2013 85 1273 10.1517/14712598.2013.819337
6. A. Caporali, and C. Emanueli MicroRNA regulation in angiogenesis Vascul. Pharmacol. 55 2011 79 86
7. K.K. Banaudha, and M. Verma The role of microRNAs in the management of liver cancer Methods Mol. Biol. 863 2012 241 251
8. P.Y. Lin, S.L. Yu, and P.C. Yang MicroRNA in lung cancer Br. J. Cancer 103 2010 1144 1148
9. Y. Ke, W. Zhao, J. Xiong, and R. Cao MiR-149 inhibits non-small-cell lung cancer cells EMT by targeting FOXM1 Biochem. Res. Int. 2013 2013 506731
10. R. Mallick, S.K. Patnaik, and S. Yendamuri MicroRNAs and lung cancer: biology and applications in diagnosis and prognosis J. Carcinog. 2010 10.4103/1477-3163.67074
11. N. Bandi MiR-15a and miR-16 are implicated in cell cycle regulation in a Rb-dependent manner and are frequently deleted or down-regulated in non-small cell lung cancer Cancer Res. 69 2009 5553 5559
12. G.A. Calin Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia Proc. Natl. Acad. Sci. USA 99 2002 15524 15529
13. Y. Chen Decreased miRNA-148a is associated with lymph node metastasis and poor clinical outcomes and functions as a suppressor of tumor metastasis in non-small cell lung cancer Oncol. Rep. 2013 1832 1840 10.3892/or.2013.2611
14. J. Yang, H. Liu, H. Wang, and Y. Sun Down-regulation of microRNA-181b is a potential prognostic marker of non-small cell lung cancer Pathol. Res. Pract. 209 2013 490 494 10.1016/j.prp.2013.04.018
15. W. Luo, B. Huang, Z. Li, H. Li, L. Sun, Q. Zhang, X. Qiu, and E. Wang MicroRNA-449a is downregulated in non-small cell lung cancer and inhibits migration and invasion by targeting c-Met PLoS One 8 2013 e64759
16. Q. Ma MicroRNA-16 represses colorectal cancer cell growth in vitro by regulating the p53/survivin signaling pathway Oncol. Rep. 29 2013 1652 1658
17. L. Chen, Q. Wang, G.D. Wang, H.S. Wang, Y. Huang, X.M. Liu, and X.H. Cai MiR-16 inhibits cell proliferation by targeting IGF1R and the Raf1-MEK1/2-ERK1/2 pathway in osteosarcoma FEBS Lett. 587 2013 1366 1372
18. J. Shen MiR-15b and miR-16 induce the apoptosis of rat activated pancreatic stellate cells by targeting Bcl-2 in vitro Pancreatology 12 2012 91 99
19. S.Z. Li The expression of hepatoma-derived growth factor in primary central nervous system lymphoma and its correlation with angiogenesis, proliferation and clinical outcome Med. Oncol. 30 2013 622
20. H.E. Tsai Up-regulation of hepatoma-derived growth factor facilities tumor progression in malignant melanoma PLoS One 8 2013 e59345
21. J. Zhang, H. Ren, P. Yuan, W. Lang, L. Zhang, and L. Mao Down-regulation of hepatoma-derived growth factor inhibits anchorage-independent growth and invasion of non-small cell lung cancer cells Cancer Res. 66 2006 18 23